The weight-loss drug revolution

0 Anmeldelser
0
Episode
1658 of 1942
Længde
17M
Sprog
Engelsk
Format
Kategori
Økonomi & Business

Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of Mounjaro. But with competitors desperate for a piece of the action, how long can these two giants stay in front?

Leanna Byrne hears from some of the companies involved, including those at the centre of the action and those developing the next wave of treatments.

Presented by Leanna Byrne and produced by Lexy O'Connor

(Image: A box of the anti-obesity drug Wegovy, including injection pens. Credit: Getty Images)


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036

Other podcasts you might like ...